FeesSafety
Pluang+

ArrowMark Financial reports estimated NAV of $20.83 as of September 30, 2026.

Market News
27 Oct 2026, 00:00 WIB
GlobeNewsWire
View Source
Neutral
ArrowMark Financial reports estimated NAV of $20.83 as of September 30, 2026.

ArrowMark Financial Corp. announced its estimated and unaudited Net Asset Value (NAV) as of September 30, 2026, at $20.83 per share. This figure provides investors with a snapshot of the company's value but is not a full financial statement. ArrowMark Financial is a closed-end fund focused on income through investments in regulatory capital securities of financial institutions. Investors should consider the risks involved and review official filings for detailed information.

ArrowMark Financial Corp.'s estimated net asset value is reported as of September 30, 2026. For readers following Financials-sector stocks, here is Pluang's market snapshot as of Oct 27, 2026 03:21 WIB: out of 142 priced US Financials stocks, 76 rose and 66 fell. Notable movers include XP at USD 15.72 with a 1-day change of -48.31% and Pluang order activity of 5% Sell / 95% Buy, BBD at USD 2.96 down 27.27% with 2% Sell / 98% Buy, and ITUB at USD 7.70 down 20.42% with 0% Sell / 100% Buy.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
15 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
15 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
27 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App